---
title: "Psych News Alert: FDA Approves Another Weight Loss Drug"
description: The U.S. Food and Drug Administration (FDA) has approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-ca...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/weight%20loss_67879417-Jun-24-2025-04-45-04-9748-PM.jpg
---

 7/19/12 12:00 AM

# FDA Approves Another Weight Loss Drug

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2012/07/fda-approves-another-weight-loss-drug.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2012/07/fda-approves-another-weight-loss-drug.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2012/07/fda-approves-another-weight-loss-drug.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2012/07/fda-approves-another-weight-loss-drug.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2012/07/fda-approves-another-weight-loss-drug.html)

| [![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/weight%20loss_67879417-Jun-24-2025-04-45-02-9928-PM.jpg?width=200&height=131&name=weight%20loss_67879417-Jun-24-2025-04-45-02-9928-PM.jpg)](https://alert.psychnews.org/hubfs/Imported_Blog_Media/weight%20loss_67879417-Jun-24-2025-04-45-04-0350-PM.jpg) |  |
| --- | --- |

The U.S. Food and Drug Administration (FDA) has approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese) or adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol. Qsymia must not be used during pregnancy because of increased risk of oral clefts (cleft lip with or without cleft palate) during the first trimester due to the topiramate component of the drug. Qsymia is also not for use in patients with glaucoma or hyperthyroidism because it can increase heart rate. The approval comes on the heels of the FDA's approval of Belviq (locaserin hydrochloride) last month as a weight-management aid. Qsymia, known as Qnexa during its development, is marketed by Vivus Inc.

Read more about Qsymia's journey to approval in *Psychiatric News*, [here](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=181090) , [here](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=1096616) , and [here](http://psychnews.psychiatryonline.org/newsarticle.aspx?articleid=1032206) .

(Image: SAJE/Shutterstock.com)

[obesity](https://alert.psychnews.org/tag/obesity), [weight loss](https://alert.psychnews.org/tag/weight-loss), [Belviq](https://alert.psychnews.org/tag/belviq), [Qsymia](https://alert.psychnews.org/tag/qsymia)

## Related posts

## [Highlights From APA’s 2018 Annual Meeting: Issue #3](https://alert.psychnews.org/2018/07/highlights-from-apas-2018-annual.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 7/12/18 12:00 AM

As ECT Marks 80th Birthday, Experts Reflect on Its Future Researchers are using neuroimaging to...

[ Read more ](https://alert.psychnews.org/2018/07/highlights-from-apas-2018-annual.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/DNA_iStock-508496956-Jun-24-2025-09-46-47-9187-PM.jpg?height=200&name=DNA_iStock-508496956-Jun-24-2025-09-46-47-9187-PM.jpg) ](https://alert.psychnews.org/2017/05/researchers-uncover-genetic-link-to.html)

[schizophrenia](https://alert.psychnews.org/tag/schizophrenia), [ajp in advance](https://alert.psychnews.org/tag/ajp-in-advance), [obesity](https://alert.psychnews.org/tag/obesity), [insulin](https://alert.psychnews.org/tag/insulin), [type 1 diabetes](https://alert.psychnews.org/tag/type-1-diabetes), [GWAS](https://alert.psychnews.org/tag/gwas), [neuroticism](https://alert.psychnews.org/tag/neuroticism), [metabolic disorder](https://alert.psychnews.org/tag/metabolic-disorder), [anorexia nervosa](https://alert.psychnews.org/tag/anorexia-nervosa), [genes](https://alert.psychnews.org/tag/genes), [autoimmune disorders](https://alert.psychnews.org/tag/autoimmune-disorders), [Cynthia Bulik](https://alert.psychnews.org/tag/cynthia-bulik)

## [Researchers Uncover Genetic Link to Anorexia](https://alert.psychnews.org/2017/05/researchers-uncover-genetic-link-to.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 5/12/17 12:00 AM

Researchers have uncovered the first genetic variant tied to anorexia nervosa, reports a study...

[ Read more ](https://alert.psychnews.org/2017/05/researchers-uncover-genetic-link-to.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/clinicaltrial_69750982-Jun-24-2025-07-30-17-6449-PM.jpg?height=200&name=clinicaltrial_69750982-Jun-24-2025-07-30-17-6449-PM.jpg) ](https://alert.psychnews.org/2011/12/reporting-of-clinical-trials-still.html)

[clinical trial](https://alert.psychnews.org/tag/clinical-trial)

## [Reporting of Clinical Trials Still Lacking](https://alert.psychnews.org/2011/12/reporting-of-clinical-trials-still.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 12/8/11 12:00 AM

[ Read more ](https://alert.psychnews.org/2011/12/reporting-of-clinical-trials-still.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T16:48:55.199Z",
  "datePublished" : "2012-07-19T04:00:00.000Z",
  "headline" : "Psych News Alert: FDA Approves Another Weight Loss Drug",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/weight%20loss_67879417-Jun-24-2025-04-45-04-9748-PM.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2012/07/fda-approves-another-weight-loss-drug.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```